53 Trademark Results found for "VYPIX"

Also try searching for:

VYPIX*

VYPI*

*PIX

VY*IX

Details	Status	Class/Description
VYSOV MET NOVARTIS AG 2016/22514 10 Aug 2016	Published	Pharmaceutical preparations Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations
VYONDYS Sarepta Therapeutics 2019/22940 14 Aug 2019	Published	Pharmaceutical preparations for the treatment of neuromuscular disease... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders.
VYNCHRO NOVARTIS AG 2018/01141 17 Jan 2018	Published	Pharmaceutical preparations Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations
VYSPREE BIOMARIN PHARMACEUTICAL INC. 2020/10153 13 May 2020	Published	Pharmaceutical preparations for the treatment of genetic diseases and ... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of genetic diseases and disorders; peptides for the treatment of genetic diseases or disorders
VYKAFTY Vertex Pharmaceuticals Incorporated 2022/07495 4 Mar 2022	Published	Pharmaceutical preparations for the treatment of cystic fibrosis. Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of cystic fibrosis.
VYZULTA Valeant Pharmaceuticals Ireland Limited 2018/36412 5 Dec 2018	Published	Ophthalmic solutions and preparations, including solutions for the red... Class 005 Class 005 Pharmaceutical Products Ophthalmic solutions and preparations, including solutions for the reduction of intraocular pressure in patients with glaucoma or ocular hypertension.
VYGLXIA Biohaven Therapeutics Ltd. 2021/28342 14 Sept 2021	Published	Medicated and pharmaceutical preparations, both prescription and over-... Class 005 Class 005 Pharmaceutical Products Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals, namely, for the treatment of central nervous system disorders, neurologic illnesses, and psychiatric illnesses; pharmaceutical preparations for the treatment of brain ischemia; pharmaceutical preparations for the treatment of brain ischemia, namely, post-stroke recovery, severe intracranial atherosclerosis, carotid endarterectomy, cardiac bypass, cerebral vasculitis, reversible cerebral vasoconstriction syndrome; pharmaceutical preparations for the treatment of brain and cord injuries; pharmaceutical preparations for the treatment of brain and cord injuries, namely, post-intracranial hemorrhage recovery, traumatic brain injury, spinal cord injury; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Alzheimer's disease (AD), Amyotrophic Lateral Sclerosis (ALS), Huntington's disease, Lewy body dementia, frontotemporal dementia, vascular dementia, Parkinson's disease, cognitive impairment of aging, progressive Multiple Sclerosis; pharmaceutical preparations for the treatment of optic and retinal neuropathies; pharmaceutical preparations for the treatment of optic and retinal neuropathies, namely, glaucoma, diabetic retinopathy, ischemic optic and retinal neuropathies; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of pain, namely, opioid sparing analgesia, chronic neuropathic pain, peripheral neuropathy, low back pain in the nature of failed back surgery syndrome, radiculopathy in the nature of sciatica, diabetic peripheral neuropathy, post-herpetic neuralgia, medication induced neuropathies, complex regional pain syndrome, fibromyalgia, chronic post-operative pain, cluster thoracotomy, phantom limb, stump neuroma; pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia; pharmaceutical preparations for symptomatic treatments of degenerative diseases; pharmaceutical preparations for symptomatic treatments of degenerative diseases, namely, breath holding in Rett syndrome, dystonias, dysphagia, gait abnormalities, bulbar function in ALS, pseudobulbar affect, levodopa-induced dyskinesias in Parkinson's disease, agitation in AD, disinhibition in dementia; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of epilepsy, namely, precision medicine - adjuvant for genetic epilepsy due to NMDA receptor mutations with hyperactivation; pharmaceutical preparations for the treatment of neuropsychiatric disorders; pharmaceutical preparations for the treatment of neuropsychiatric disorders, namely, treatment resistant depression, Post Traumatic Stress Disorder (PTSD) in the nature of hyperarousal, substance abuse disorders, addiction disorders, Obsessive Compulsive Disorder (OCD), hoarding, trichotillomania, eating disorders, Generalized Anxiety Disorder (GAD), adjustment disorders, panic disorder, major depressive episode, bipolar disorder in the nature of manic and depressive episodes, dysthymia, cyclothymia, psychotic disorders, schizophrenia; pharmaceutical preparations for the treatment of cerebellar disorders; pharmaceutical preparations for the treatment of cerebellar disorders, namely, spinocerebellar ataxia, Friedriech's ataxia, multisystem atrophy, essential tremor; pharmaceutical preparations for the treatment of hearing disorders, tinnitus, delirium, sleep disorders, parasomnias, learning disorders, Attention Deficit Disorder (ADD), Pervasive Developmental Disorders (PDD), Asperger's syndrome, autism, menopausal hot flashes
VYVGART Argenx B.V. 2020/17798 21 Jul 2020	Published	Pharmaceuticals; pharmaceutical preparations and compositions Class 005 Class 005 Pharmaceutical Products Pharmaceuticals; pharmaceutical preparations and compositions
VYSINARA Johnson & Johnson 2011/10074 28 Apr 2011	Published	Human pharmaceuticals Class 005 Class 005 Pharmaceutical Products Human pharmaceuticals
VYNDAQEL PFIZER INC. 2011/09029 14 Apr 2011	Published	Pharmaceutical, veterinary and sanitary preparations; dietetic substan... Class 005 Class 005 Pharmaceutical Products Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

Published

VYSOV MET

NOVARTIS AG

2016/22514 · 10 Aug 2016

005

Pharmaceutical preparations

Published

VYONDYS

Sarepta Therapeutics

2019/22940 · 14 Aug 2019

005

Pharmaceutical preparations for the treatment of neuromuscular disease...

Published

VYNCHRO

NOVARTIS AG

2018/01141 · 17 Jan 2018

005

Pharmaceutical preparations

Published

VYSPREE

BIOMARIN PHARMACEUTICAL INC.

2020/10153 · 13 May 2020

005

Pharmaceutical preparations for the treatment of genetic diseases and ...

Published

VYKAFTY

Vertex Pharmaceuticals Incorporated

2022/07495 · 4 Mar 2022

005

Pharmaceutical preparations for the treatment of cystic fibrosis.

Published

VYZULTA

Valeant Pharmaceuticals Ireland Limited

2018/36412 · 5 Dec 2018

005

Ophthalmic solutions and preparations, including solutions for the red...

Published

VYGLXIA

Biohaven Therapeutics Ltd.

2021/28342 · 14 Sept 2021

005

Class 005

Pharmaceutical Products

Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals, namely, for the treatment of central nervous system disorders, neurologic illnesses, and psychiatric illnesses; pharmaceutical preparations for the treatment of brain ischemia; pharmaceutical preparations for the treatment of brain ischemia, namely, post-stroke recovery, severe intracranial atherosclerosis, carotid endarterectomy, cardiac bypass, cerebral vasculitis, reversible cerebral vasoconstriction syndrome; pharmaceutical preparations for the treatment of brain and cord injuries; pharmaceutical preparations for the treatment of brain and cord injuries, namely, post-intracranial hemorrhage recovery, traumatic brain injury, spinal cord injury; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Alzheimer's disease (AD), Amyotrophic Lateral Sclerosis (ALS), Huntington's disease, Lewy body dementia, frontotemporal dementia, vascular dementia, Parkinson's disease, cognitive impairment of aging, progressive Multiple Sclerosis; pharmaceutical preparations for the treatment of optic and retinal neuropathies; pharmaceutical preparations for the treatment of optic and retinal neuropathies, namely, glaucoma, diabetic retinopathy, ischemic optic and retinal neuropathies; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of pain, namely, opioid sparing analgesia, chronic neuropathic pain, peripheral neuropathy, low back pain in the nature of failed back surgery syndrome, radiculopathy in the nature of sciatica, diabetic peripheral neuropathy, post-herpetic neuralgia, medication induced neuropathies, complex regional pain syndrome, fibromyalgia, chronic post-operative pain, cluster thoracotomy, phantom limb, stump neuroma; pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia; pharmaceutical preparations for symptomatic treatments of degenerative diseases; pharmaceutical preparations for symptomatic treatments of degenerative diseases, namely, breath holding in Rett syndrome, dystonias, dysphagia, gait abnormalities, bulbar function in ALS, pseudobulbar affect, levodopa-induced dyskinesias in Parkinson's disease, agitation in AD, disinhibition in dementia; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of epilepsy, namely, precision medicine - adjuvant for genetic epilepsy due to NMDA receptor mutations with hyperactivation; pharmaceutical preparations for the treatment of neuropsychiatric disorders; pharmaceutical preparations for the treatment of neuropsychiatric disorders, namely, treatment resistant depression, Post Traumatic Stress Disorder (PTSD) in the nature of hyperarousal, substance abuse disorders, addiction disorders, Obsessive Compulsive Disorder (OCD), hoarding, trichotillomania, eating disorders, Generalized Anxiety Disorder (GAD), adjustment disorders, panic disorder, major depressive episode, bipolar disorder in the nature of manic and depressive episodes, dysthymia, cyclothymia, psychotic disorders, schizophrenia; pharmaceutical preparations for the treatment of cerebellar disorders; pharmaceutical preparations for the treatment of cerebellar disorders, namely, spinocerebellar ataxia, Friedriech's ataxia, multisystem atrophy, essential tremor; pharmaceutical preparations for the treatment of hearing disorders, tinnitus, delirium, sleep disorders, parasomnias, learning disorders, Attention Deficit Disorder (ADD), Pervasive Developmental Disorders (PDD), Asperger's syndrome, autism, menopausal hot flashes

Medicated and pharmaceutical preparations, both prescription and over-...

Published

VYVGART

Argenx B.V.

2020/17798 · 21 Jul 2020

005

Pharmaceuticals; pharmaceutical preparations and compositions

Published

VYSINARA

Johnson & Johnson

2011/10074 · 28 Apr 2011

005

Human pharmaceuticals

Published

VYNDAQEL

PFIZER INC.

2011/09029 · 14 Apr 2011

005

Pharmaceutical, veterinary and sanitary preparations; dietetic substan...

Owners

Nicoventures holdings limited (6)

Novartis ag (5)

Abbott medical optics inc (3)

Metrofile management services (proprietary) limited (3)

Allergan (2)

Abbott molecular inc. (2)

Pfizer inc. an entity organized under the laws (2)

Syngenta crop protection ag (2)

Vyaire medical (2)

Acino pharma ag (1)

Categories

Class 5 (30)

Class 34 (5)

Class 9 (4)

Class 10 (4)

Class 1 (3)

Class 35 (2)

Class 25 (1)

Class 38 (1)

Class 39 (1)

Class 42 (1)

Correspondents

Adams & adams (14)

Spoor & fisher (11)

Spoor and fisher (6)

Webber wentzel (4)

Adams & adams (3)

Dm kisch inc (3)

Edward nathan sonneberg inc (1)

Edward nathan sonnenbergs inc (1)

Display

List View

Grid View

Apply for Trade mark

Select countries to protect your logo Trade mark

Trade mark Name

Country Selected

South Africa

R2,000/ 1 class + gov fee

United States

R1,843/ 1 class + gov fee

Canada

R11,151/ 1 class + gov fee

Mexico

R9,289/ 1 class + gov fee

European Union

R13,031/ 1 class + gov fee

China

R9,289/ 1 class + gov fee

South Korea

R13,012/ 1 class + gov fee

Japan

R14,873/ 1 class + gov fee

India

R1,843/ 1 class + gov fee

United Kingdom

R9,289/ 1 class + gov fee

Australia

R5,566/ 1 class + gov fee

Israel

R13,012/ 1 class + gov fee

United Arab Emirates

R13,012/ 1 class + gov fee

New Zealand

R13,012/ 1 class + gov fee

Brazil

R9,289/ 1 class + gov fee

Taiwan

R14,873/ 1 class + gov fee

Ukraine

R14,873/ 1 class + gov fee

Indonesia

R13,012/ 1 class + gov fee

South Africa

R2,000/ 1 class + gov fee

Singapore

R14,873/ 1 class + gov fee

Saudi Arabia

R14,873/ 1 class + gov fee

Afghanistan

R14,873/ 1 class + gov fee

Algeria

R14,873/ 1 class + gov fee

Argentina

R7,428/ 1 class + gov fee

Austria

R16,735/ 1 class + gov fee

Bahrain

R13,012/ 1 class + gov fee

Bangladesh

R11,151/ 1 class + gov fee

Benelux

R18,596/ 1 class + gov fee

Bhutan

R16,735/ 1 class + gov fee

Bolivia

R14,873/ 1 class + gov fee

Botswana

R24,181/ 1 class + gov fee

British Virgin Islands

R22,319/ 1 class + gov fee

Bulgaria

R14,873/ 1 class + gov fee

Cambodia

R14,873/ 1 class + gov fee

Chile

R9,289/ 1 class + gov fee

Colombia

R13,012/ 1 class + gov fee

Congo

R22,319/ 1 class + gov fee

Costa Rica

R16,735/ 1 class + gov fee

Croatia

R16,735/ 1 class + gov fee

Cyprus

R18,596/ 1 class + gov fee

Czech Republic

R16,735/ 1 class + gov fee

Denmark

R14,873/ 1 class + gov fee

Curacao

R22,319/ 1 class + gov fee

Macau

R13,012/ 1 class + gov fee

Dominican Republic

R16,735/ 1 class + gov fee

Aruba

R22,319/ 1 class + gov fee

Greenland

R14,873/ 1 class + gov fee

Ecuador

R14,873/ 1 class + gov fee

Egypt

R13,012/ 1 class + gov fee

El Salvador

R14,873/ 1 class + gov fee

Ethiopia

R20,458/ 1 class + gov fee

France

R16,735/ 1 class + gov fee

Gaza

R14,873/ 1 class + gov fee

Germany

R16,735/ 1 class + gov fee

Greece

R14,873/ 1 class + gov fee

Guatemala

R16,735/ 1 class + gov fee

Haiti

R16,735/ 1 class + gov fee

Honduras

R16,735/ 1 class + gov fee

Hong Kong (SAR)

R16,735/ 1 class + gov fee

Hungary

R20,458/ 1 class + gov fee

Iraq

R27,904/ 1 class + gov fee

Italy

R16,735/ 1 class + gov fee

Jordan

R14,873/ 1 class + gov fee

Kazakhstan

R14,873/ 1 class + gov fee

Kenya

R16,735/ 1 class + gov fee

Kuwait

R14,873/ 1 class + gov fee

Laos

R13,012/ 1 class + gov fee

Lebanon

R18,596/ 1 class + gov fee

Lesotho

R22,319/ 1 class + gov fee

Libya

R16,735/ 1 class + gov fee

Madrid Protocol (WIPO)

R37,211/ 1 class + gov fee

Malawi

R20,458/ 1 class + gov fee

Malaysia

R13,012/ 1 class + gov fee

Maldives

R18,596/ 1 class + gov fee

Morocco

R18,596/ 1 class + gov fee

Mozambique

R16,735/ 1 class + gov fee

Myanmar

R14,873/ 1 class + gov fee

Namibia

R14,873/ 1 class + gov fee

Nepal

R13,012/ 1 class + gov fee

Nicaragua

R16,735/ 1 class + gov fee

Norway

R16,735/ 1 class + gov fee

Oman

R20,458/ 1 class + gov fee

Pakistan

R14,873/ 1 class + gov fee

Panama

R16,735/ 1 class + gov fee

Paraguay

R16,735/ 1 class + gov fee

Peru

R14,873/ 1 class + gov fee

Philippines

R16,735/ 1 class + gov fee

Poland

R9,289/ 1 class + gov fee

Portugal

R16,735/ 1 class + gov fee

Puerto Rico

R16,735/ 1 class + gov fee

Qatar

R14,873/ 1 class + gov fee

Romania

R16,735/ 1 class + gov fee

Serbia

R16,735/ 1 class + gov fee

Slovakia

R16,735/ 1 class + gov fee

Spain

R16,735/ 1 class + gov fee

Sri Lanka

R13,012/ 1 class + gov fee

Swaziland

R24,181/ 1 class + gov fee

Sweden

R14,873/ 1 class + gov fee

Switzerland

R16,735/ 1 class + gov fee

Thailand

R14,873/ 1 class + gov fee

Tunisia

R16,735/ 1 class + gov fee

Turkey

R14,873/ 1 class + gov fee

Uganda

R13,012/ 1 class + gov fee

United Republic of Tanzania

R13,012/ 1 class + gov fee

Uruguay

R14,873/ 1 class + gov fee

Venezuela

R16,735/ 1 class + gov fee

Vietnam

R14,873/ 1 class + gov fee

West Bank, Palestine

R14,873/ 1 class + gov fee

Yemen

R31,626/ 1 class + gov fee

Albania

R16,735/ 1 class + gov fee

Andorra

R16,735/ 1 class + gov fee

Angola

R24,181/ 1 class + gov fee

Antigua and Barbuda

R22,319/ 1 class + gov fee

Armenia

R14,873/ 1 class + gov fee

Azerbaijan

R14,873/ 1 class + gov fee

Bahamas

R26,042/ 1 class + gov fee

Barbados

R24,181/ 1 class + gov fee

Belgium

R18,596/ 1 class + gov fee

Belize

R24,181/ 1 class + gov fee

Benin

R14,873/ 1 class + gov fee

Bosnia and Herzegovina

R18,596/ 1 class + gov fee

Brunei

R24,181/ 1 class + gov fee

Burkina Faso

R14,873/ 1 class + gov fee

Burundi

R22,319/ 1 class + gov fee

Cabo Verde

R16,735/ 1 class + gov fee

Cameroon

R14,873/ 1 class + gov fee

Central African Republic (CAR)

R14,873/ 1 class + gov fee

Chad

R14,873/ 1 class + gov fee

Comoros

R14,873/ 1 class + gov fee

Cote d'Ivoire

R14,873/ 1 class + gov fee

Czechia

R18,596/ 1 class + gov fee

Djibouti

R22,319/ 1 class + gov fee

Dominica

R24,181/ 1 class + gov fee

Equatorial Guinea

R14,873/ 1 class + gov fee

Eritrea

R18,596/ 1 class + gov fee

Estonia

R24,181/ 1 class + gov fee

Eswatini

R24,181/ 1 class + gov fee

Fiji

R16,735/ 1 class + gov fee

Finland

R13,012/ 1 class + gov fee

Gabon

R14,873/ 1 class + gov fee

Gambia

R16,735/ 1 class + gov fee

Georgia

R14,873/ 1 class + gov fee

Ghana

R18,596/ 1 class + gov fee

Grenada

R24,181/ 1 class + gov fee

Guinea

R14,873/ 1 class + gov fee

Guinea-Bissau

R14,873/ 1 class + gov fee

Guyana

R24,181/ 1 class + gov fee

Iceland

R24,181/ 1 class + gov fee

Ireland

R14,873/ 1 class + gov fee

Jamaica

R22,319/ 1 class + gov fee

Kiribati

R18,596/ 1 class + gov fee

Kosovo

R16,735/ 1 class + gov fee

Kyrgyzstan

R16,735/ 1 class + gov fee

Latvia

R13,012/ 1 class + gov fee

Liberia

R18,596/ 1 class + gov fee

Liechtenstein

R18,596/ 1 class + gov fee

Lithuania

R13,012/ 1 class + gov fee

Luxembourg

R18,596/ 1 class + gov fee

Madagascar

R18,596/ 1 class + gov fee

Mali

R14,873/ 1 class + gov fee

Malta

R11,151/ 1 class + gov fee

Marshall Islands

R18,596/ 1 class + gov fee

Mauritania

R14,873/ 1 class + gov fee

Mauritius

R18,596/ 1 class + gov fee

Micronesia

R18,596/ 1 class + gov fee

Moldova

R18,596/ 1 class + gov fee

Monaco

R26,042/ 1 class + gov fee

Mongolia

R11,151/ 1 class + gov fee

Montenegro

R16,735/ 1 class + gov fee

Nauru

R18,596/ 1 class + gov fee

Netherlands

R18,596/ 1 class + gov fee

Niger

R14,873/ 1 class + gov fee

Nigeria

R7,428/ 1 class + gov fee

North Macedonia

R16,735/ 1 class + gov fee

Palau

R18,596/ 1 class + gov fee

Palestine

R18,596/ 1 class + gov fee

Papua New Guinea

R14,873/ 1 class + gov fee

Rwanda

R18,596/ 1 class + gov fee

Saint Kitts and Nevis

R24,181/ 1 class + gov fee

Saint Lucia

R24,181/ 1 class + gov fee

Saint Vincent and the Grenadines

R24,181/ 1 class + gov fee

Samoa

R22,319/ 1 class + gov fee

San Marino

R18,596/ 1 class + gov fee

Sao Tome and Principe

R18,596/ 1 class + gov fee

Senegal

R14,873/ 1 class + gov fee

Seychelles

R18,596/ 1 class + gov fee

Sierra Leone

R18,596/ 1 class + gov fee

Slovenia

R16,735/ 1 class + gov fee

Solomon Islands

R18,596/ 1 class + gov fee

Somalia

R18,596/ 1 class + gov fee

South Sudan

R18,596/ 1 class + gov fee

Suriname

R29,765/ 1 class + gov fee

Tajikistan

R14,873/ 1 class + gov fee

Tanzania

R13,012/ 1 class + gov fee

Timor-Leste

R18,596/ 1 class + gov fee

Togo

R14,873/ 1 class + gov fee

Tonga

R24,181/ 1 class + gov fee

Trinidad and Tobago

R22,319/ 1 class + gov fee

Turkmenistan

R14,873/ 1 class + gov fee

Tuvalu

R18,596/ 1 class + gov fee

Uzbekistan

R13,012/ 1 class + gov fee

Vanuatu

R22,319/ 1 class + gov fee

Zambia

R16,735/ 1 class + gov fee

Zimbabwe

R16,735/ 1 class + gov fee

OAPI

R16,735/ 1 class + gov fee

ARIPO

R18,596/ 1 class + gov fee

Page 4 of 6